Top stories in endocrinology: Blood test estimates final menstrual period, FDA OKs novel thyroid eye disease treatment

Researchers said a blood test can show when a woman may experience her last menstrual period. This was the top story in endocrinology last week.

The FDA’s approval of teprotumumab, the first drug for adults with thyroid eye disease, was another top story.

Get all the top endocrinology news here.

Blood test can predict final menstrual period

The amount of anti-Müllerian hormone in the blood can be used to estimate when a woman will undergo her final menstrual period and, in general, does so better than measuring follicle-stimulating hormone, according to an analysis of the Study of Women’s Health Across the Nation. Read more.

FDA approves teprotumumab for thyroid eye disease

 

Breastfeeding, pregnancy associated with reduced risk for early menopause.

Source: Shutterstock

The FDA recently approved the human monoclonal antibody teprotumumab for the treatment of adults with thyroid eye disease, marking the first drug approved for the condition, according to an agency press release. Read more.

Oral medication for uterine fibroids shows promise for limiting menstrual bleeding

The oral gonadotropin-releasing hormone antagonist elagolix substantially decreased excessive menstrual bleeding for women with uterine fibroids, according to findings published in The New England Journal of Medicine. Read more.

Breastfeeding, pregnancy associated with reduced risk for early menopause

Parity and breastfeeding are each independently associated with a significantly lower risk for early natural menopause, according to an analysis of the Nurses’ Health Study II cohort. Read more.

Diabetes educator organization rebrands with new name: Association of Diabetes Care & Education Specialists

The former American Association of Diabetes Educators is now the Association of Diabetes Care & Education Specialists, or ADCES, part of a larger rebranding effort that includes new names for the specialty title and credentials for diabetes educators, according to an association press release. Read more.